Compound 140
Identifiers
- Canonical SMILES:
Oc1c(Cl)cc(Cl)cc1S(=O)(=O)N(Cc1ccc(F)cc1)Cc1ccc(cc1)C(=O)N1CCN(CC1)c1cnccn1
- IUPAC name:
3,5-dichloro-N-[(4-fluorophenyl)methyl]-2-hydroxy-N-[[4-(4-pyrazin-2-ylpiperazine-1-carbonyl)phenyl]methyl]benzenesulfonamide
- InChi:
InChI=1S/C29H26Cl2FN5O4S/c30-23-15-25(31)28(38)26(16-23)42(40,41)37(19-21-3-7-24(32)8-4-21)18-20-1-5-22(6-2-20)29(39)36-13-11-35(12-14-36)27-17-33-9-10-34-27/h1-10,15-17,38H,11-14,18-19H2
- InChiKey:
MXHCHTYGBFEAAC-UHFFFAOYSA-N
External links
44595109 |
External search
Bibliography (1)
Publication | Name |
---|---|
Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai, Kap-Sun Yeung, Bristol-Myers Squibb Company. . Hydroxyphenylsulfonamides as antiapoptotic bcl inhibitors None. | 140 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.18 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 629.11 g/mol | |||
HBA | 9 | |||
HBD | 1 | |||
HBA + HBD | 10 | |||
AlogP | 4.72 | |||
TPSA | 106.94 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2009152082 | 140 | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 6.18 | |
WO2009152082 | 140 | MCL1 Q07820 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 5.76 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4474 | N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide | DB07115 | |
0.4421 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
0.4258 | Sulfabenzamide | DB09355 | |
0.4257 | ABT-639 | DB15055 | |
0.4128 | Avagacestat | DB11893 | |
0.4097 | Pilaralisib | DB11772 | |
0.4089 | Taprenepag | DB12623 | |
0.4070 | 4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE | DB08495 | |
0.4059 | Delavirdine | DB00705 | |
0.4053 | Evatanepag | DB12022 | |
0.4052 | 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide | DB02429 | |
0.4051 | 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide | DB04180 | |
0.4051 | Saccharin | DB12418 | |
0.4051 | 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide | DB02221 | |
0.4039 | 3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE | DB08487 |